Peer-reviewedCC BYBiomedicines
Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis
- 1Department of Pulmonary Medicine, Faculty of Medicine, Kocaeli University, 41380 Kocaeli, Turkey; (T.O.); (H.K.); (S.A.B.); (B.O.); (H.B.); (I.B.)
- 2Department of Pulmonary Medicine, Private Konak Hospital, 41100 Kocaeli, Turkey
Related
- Data-driven reweighting of the Charlson and Elixhauser comorbidity indices using German claims data: development for in-hospital mortality only, external validation across clinical and health-economic outcomes.
- H2FPEF Score and Charlson Comorbidity Index as Independent Predictors of Cardiovascular Outcomes in Elderly Patients Undergoing Geriatric Rehabilitation
- Comorbidity Count Versus the Charlson Comorbidity Index in Predicting Hospital Stay After Hip Fracture in Older Adults: A Retrospective Cohort Study.
- Radiologic Sarcopenia and Charlson Comorbidity Index in the Head and Neck Free Flap Population
- The Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio for Mortality in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
BibTeX
@article{onyilmaz2026association,
title = {{Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis}},
author = {Tugba Onyilmaz and Gozde Oksuzler Kizilbay and Huseyin Kaya and Serap Argun Baris and Bengugul Ozturk and Hasim Boyaci and Ilknur Basyigit},
journal = {Biomedicines},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13701863},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis
AU - Tugba Onyilmaz
AU - Gozde Oksuzler Kizilbay
AU - Huseyin Kaya
AU - Serap Argun Baris
AU - Bengugul Ozturk
AU - Hasim Boyaci
AU - Ilknur Basyigit
PY - 2026
DA - 2026/09/25
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701863
SN - 2227-9059
ER -